Here's the Incredible Promise of Medicine That Targets Our DNA

 
Share
 

This series is archived ("HTTP Redirect" status)

Please note series archiving is a new, experimental, feature of Player FM with the aim of helping users understand how we fetch series and report on any issues.

Replaced by: Decrypted

When? This feed was archived on June 19, 2017 20:11 (). Last successful fetch was on June 17, 2017 19:19 ()

Why? HTTP Redirect status. The feed permanently redirected to another series.

What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.


 

Danger zone

Series is public
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
Around the world, people suffer from a genetic condition called hemophilia. Even with expensive and time-consuming treatments, simple injuries for these patients hold the threat of turning into serious complications and even life-threatening events. But now, one biotech company has stumbled upon what very early trials suggest could be a "cure" -- something that, with a single intravenous drip, essentially corrects the genetic mutation that causes the disorder. This week, Bloomberg's Doni Bloomfield visits the scientists behind this treatment and a patient who has actually tried it. If it works, researchers may have pushed the door open to a whole new world of treatments that tackle these diseases at their source: our DNA.

50 episodes available. A new episode about every 7 days averaging 11 mins duration .